PURPOSE:It has been suggested that cardiorespiratory fitness (CRF) is associated with favorable health outcomes independent of comorbidities, including obesity. However, relatively few studies have assessed the association between CRF and mortality risk in obese women. Thus, in the present work we aimed to assess the relationship between CRF and risk of mortality among obese women. METHODS: Female (N=39,556) US Veterans completed a symptom-limited exercise treadmill test (ETT) between 1999-2020 using the Bruce Protocol. Of those 28,681 were classified as obese based on body mass index (BMI) ≥30.0 kg/m 2 criteria. We established four CRF categories based on age-specific quartiles of peak metabolic equivalents (METs) achieved: Least-Fit (n=8,005), 475), 905) and 296). Multivariate Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for death events across CRF categories. RESULTS: During the follow-up period (median=8.0 years), 1,174 women died (48.1 events/10,000 person-years of observation). Body weight in those within the Least-Fit CRF category was significantly higher when compared to women in the High-Fit category (90±17 vs. 78±11 kg, p<0.001). After adjustments for age, race, hypertension, diabetes, smoking status, major adverse cardiovascular event, breast or lung cancer and heart failure, mortality risk was 18% lower for each 1-MET increase in exercise capacity (HR: 0.82, 95% CI: 0.79-0.84). When CRF categories were considered, comparisons to the Least-Fit category (referent) revealed a progressive decline in risk with higher CRF status. Specifically, mortality risk was 32% lower for Low-Fit women (HR: 0.68, 95% CI: 0.62-0.76), 55% lower (HR: 0.45, 95% CI: 0.38-0.53) for Moderate-Fit, and 68% lower (HR: 0.32, 95% CI: 0.26-0.41) for those in the High-Fit category. CONCLUSIONS: In obese women, CRF was inversely associated with mortality risk and followed a dose-response pattern. These findings support the concept that adequate physical activity that leads to increased CRF is protective against premature mortality in obese women.